IL6 and colitis: GrTP showed a similar efficacy to sulfasalazine in reducing inflammatory markers (TNFα, IL-6 and serum amyloid A), restoring concentrations of antioxidant agents (glutathione and cysteine) and attenuating colitis in murine models of both UC and CD [22].